Propanc Biopharma, Inc.

PPCB ·Healthcare, Drug Manufacturers - General, Australia
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
EFFECT Feb 11, 2022
CORRESP Feb 10, 2022
S-1/A Feb 10, 2022
UPLOAD Feb 9, 2022
S-1 Feb 3, 2022
EFFECT Jan 14, 2022
POS AM Jan 10, 2022
8-K Jan 10, 2022
8-K Dec 13, 2021
8-K Dec 7, 2021
8-K Dec 1, 2021
10-Q Nov 12, 2021
8-K Oct 27, 2021
10-K Sep 28, 2021
8-K Sep 28, 2021
SC 13G Sep 8, 2021 SC 13G
8-K Aug 25, 2021
4 Aug 20, 2021
4 Aug 20, 2021
3 Aug 20, 2021
8-K Aug 18, 2021
10-Q May 14, 2021
8-K Mar 19, 2021
10-Q Feb 12, 2021
8-K Jan 11, 2021
← Newer Page 7 of 18 · 434 filings Older →